By Darrell S. Rigel, MD, Clinical Professor Department of Dermatology New York University Medical School, Adjunct Clinical Professor Department of Dermatology Mount Sinai School of Medicine, New York, NY; Robert Friedman, MD, Clinical Assistant Professor Department of Dermatology New York University Medical School, New York, NY; Leonard M. Dzubow, MD, Clinical Professor of Dermatology, Department of Dermatology, University of Pennsylvania, Philadelphia, PA; Douglas S. Reintgen, MD, Associate Professor of Surgery University of South Florida College of Medicine Program Leader Cutaneous Oncology; H. Lee Moffitt Cancer Center; Jean-Claude Bystryn, MD, Professor, Department of Dermatology, New York University School of Medicine; Director of Melanoma Immunotherapy Clinic, NYU Kaplan Cancer Center, New York, NY, USA; and Robin Marks, MB, BS, MPH, FRACP, FACD, Professor of Dermatology Department of Medicine University of Melbourne, Melbourne, Australia |